Item View & Download Statistics: Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Geo Map
| Region | # |
|---|---|
| NA - North America | 62 |
| AS - Asia, other | 19 |
| EU - Europe | 14 |
| Unknown | 7 |
| Total | 102 |
| Country | # |
|---|---|
| US - United States of America | 62 |
| SG - Singapore | 13 |
| IE - Ireland | 4 |
| ES - Spain | 3 |
| JP - Japan | 3 |
| CN - China | 2 |
| GB - United Kingdom | 2 |
| RU - Russian Federation | 2 |
| DE - Germany | 1 |
| HK - Hong Kong | 1 |
| other - Other Country | 9 |
| Total | 102 |
| City | # |
|---|---|
| Ashburn | 10 |
| Council Bluffs | 6 |
| Dublin | 4 |
| Kanazawa | 3 |
| Chicago | 2 |
| Oldham | 2 |
| Basauri | 1 |
| Boardman | 1 |
| Des Moines | 1 |
| Dongyang | 1 |
| other | 71 |
| Total | 102 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 8 | 4 | 19 |
| 2022 | 7 | 2 | 0 | 1 | 0 | 1 | 0 | 0 | 2 | 6 | 0 | 2 | 21 |
| 2023 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 3 | 8 |
| 2024 | 14 | 2 | 1 | 13 | 0 | 11 | 3 | 0 | 0 | 6 | 0 | 0 | 50 |
| 2025 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Ever | 102 | ||||||||||||